Rodman David Malcom

Chief Medical OfficerMineralys Therapeutics, Inc. (MLYS) · full profile →Form 4 · filed Mar 16, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$543K
Net Open-Market Flow
-$543K
Transactions
10
7 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 13, 2026Sell(S)253$27.82$7K76K
Mar 13, 2026Option exercise(M)4K$10.20$36K86K
Mar 13, 2026Sell(S)11K$25.91$278K79K
Mar 13, 2026Sell(S)3K$27.37$84K76K
Mar 13, 2026Option exercise(M)4K$14.25$59K90K
Mar 12, 2026Option exercise(M)6K$1.08$7K89K
Mar 12, 2026Sell(S)6K$27.37$174K82K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 13, 2026Option exercise(M)4K$0124K
Mar 13, 2026Option exercise(M)4K$096K
Mar 12, 2026Option exercise(M)6K$025K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001933414-26-000058) within minutes of acceptance. Every field above traces to the original document. Verify it directly: